Tag Archives: LU 177

FDA Approves Amendment for PRRT Clinical Trial in Texas

BREAKING NEWS:  The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate in patients who have predominately liver metastasis … Continue reading

Posted in carcinoid, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to a … Continue reading

Posted in neuroendocrine tumors, carcinoid and neuroendocrine tumor conferences, carcinoid testing, nuclear medicine tests, nuclear imaging, rare cancers, rare diseases, resources for carcinoid and NET patients, carcinoid and neuroendocrine tumor treatments, carcinoid doctors, liver cancer treatments, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate.   Ebrahim S. Delpassand, MD, chief executive officer and medical director of Excel Diagnostics, has announced that … Continue reading

Posted in carcinoid, carcinoid and neuroendocrine tumor treatments, carcinoid doctors, carcinoid specialists, NET (neuroendocrine tumor) cancer, neuroendocrine cancer, neuroendocrine tumors, nuclear imaging, rare cancers, rare diseases, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 19 Comments